Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.

Antineutrophil cytoplasmic antibodies (ANCA) have been reported in up to 87% of patients with primary sclerosing cholangitis with or without ulcerative colitis (PSC +/- UC) and in 68% of those with UC only. Compared with other liver and diarrhoeal diseases, ANCA have high specificity for PSC (+/- UC) and UC only. This study aimed to determine the prevalence and significance of ANCA in these two diseases and whether the ANCA titre or IgG subclass, or both, could distinguish between PSC + UC and UC only. Subjects included 63 patients with PSC, 85 with UC, 17 with coeliac disease, and 10 with dermatitis herpeteformis and 36 normal subjects. ANCA was detected using the immunoalkaline phosphatase method. The IgG subclass of ANCA was determined in 27 PSC + UC and 30 UC only patients using a panel of mouse monoclonal antibodies specific for the IgG subclasses. At a serum dilution of 1:5, ANCA had a diagnostic sensitivity of 65% for all PSC and 45% for UC only. For PSC + UC the sensitivity was 70% at 1:5 (p = 0.004 v UC only). At 1:50, the sensitivity values were 54% and 25% respectively for PSC + UC and UC only (p = 0.0006). In PSC, ANCA positivity was significantly associated with extensive involvement of the biliary tree but not with other clinical parameters. In UC only, the median disease duration was significantly greater in ANCA positive patients. The PSC + UC ANCA showed increased IgG3 compared with UC only ANCA (p < 0.05), together with increased IgG2 and IgG4 (p = NS). ANCA is a diagnostic marker in PSC and UC. While the higher titres and different IgG subclass distribution of ANCA in PSC + UC patients compared with those with UC only may reflect differences in underlying immune regulation, determination of the ANCA titre and IgG subclass is unlikely to have a role in distinguishing between PSC + UC and UC only ANCA. Future identification of the antigen(s) for ANCA should allow the development of a more sensitive and specific test for the diagnosis of these two conditions and also determine if ANCA is associated with UC or PSC.

[1]  R. Goldschmeding,et al.  Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. , 1994, Journal of clinical pathology.

[2]  W. Selby,et al.  Anti‐neutrophil cytoplasmic antibody: A prognostic indicator in primary sclerosing cholangitis , 1994, Journal of gastroenterology and hepatology.

[3]  C. Kallenberg,et al.  Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases , 1993, Hepatology.

[4]  R. Chapman,et al.  Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood? , 1993, Gut.

[5]  K. Kaneko,et al.  Is p-ANCA in ulcerative colitis directed against β-glucuronidase? , 1993, The Lancet.

[6]  G. Bodemar,et al.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. , 1993, Gut.

[7]  J. Grünfeld,et al.  Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis , 1992, Clinical and experimental immunology.

[8]  R. Chapman,et al.  Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. , 1992, Gut.

[9]  A. Ljungh,et al.  β-glucuronidase antibodies in ulcerative colitis , 1992, The Lancet.

[10]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[11]  F. Seibold,et al.  Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis , 1991, Hepatology.

[12]  A. Weetman,et al.  IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. , 1991, Clinical and experimental immunology.

[13]  S. Targan,et al.  Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. , 1991, Gastroenterology.

[14]  R. Wiesner,et al.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. , 1991, Gastroenterology.

[15]  P. Limburg,et al.  Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders , 1991, Clinical and experimental immunology.

[16]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.

[17]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[18]  P. Schur.  IgG subclasses--a review. , 1987, Annals of allergy.

[19]  E. Chan,et al.  IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. , 1986, Journal of immunology.

[20]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[21]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .

[22]  L. Witts,et al.  Cortisone in Ulcerative Colitis , 1954 .

[23]  Wilson Ts.  CURE OF UTERINE PROLAPSE BY RE-EDUCATION OF THE MUSCLES CONSTRICTING THE VAGINA , 1924 .

[24]  A. Ljungh,et al.  beta-Glucuronidase antibodies in ulcerative colitis. , 1992, Lancet.

[25]  S. Truelove,et al.  Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.